The latest price target for Insulet (NASDAQ:PODD) was reported by Barclays on November 11, 2024. The analyst firm set a price target for $234.00 expecting PODD to fall to within 12 months (a possible -11.00% downside). 26 analyst firms have reported ratings in the last year.

The latest analyst rating for Insulet (NASDAQ:PODD) was provided by Barclays, and Insulet maintained their equal-weight rating.

The last upgrade for Insulet Corp happened on May 7, 2024 when Wolfe Research raised their price target to $200. Wolfe Research previously had a peer perform for Insulet Corp.

The last downgrade for Insulet Corp happened on June 10, 2024 when OTR Global changed their price target from N/A to N/A for Insulet Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insulet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insulet was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.

While ratings are subjective and will change, the latest Insulet (PODD) rating was a maintained with a price target of $220.00 to $234.00. The current price Insulet (PODD) is trading at is $262.93, which is out of the analyst’s predicted range.